Chen et al. treated cervical cancer cell lines with the HDAC6-specific inhibitor tubastatin-A which blocked stromal-interaction molecule 1 (STIM1) trafficking and repressed the activation of STIM1-mediated store-operated Ca2+ entry (SOCE) [76]. The gene discussed is STIM1; the disease is cervical carcinoma.